1-20 of 26
Gregory P. Kaufman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Initial Clinical Results and Immune Correlates of a Phase 2 Study of Daratumumab, Bortezomib, Dexamethasone Followed By a Proteasome Inhibitor in -Class Transition ( i CT) to Daratumumab, Ixazomib, Dexamethasone in Relapsed Refractory Multiple Myeloma

Hans C. Lee, June Li, Heather Lin, Astrid D. Murga, Gabriela M Rodriguez, Mostafa E. Mohamed, Jared Henderson, Sarah Rodriguez, Melody R. Becnel, Donna M. Weber, Swami P. Iyer, Gregory P. Kaufman, Sheeba K. Thomas, Elisabet E. Manasanch, Krina K. Patel, Stephen J. Noga, Michael R. Green, Robert Z. Orlowski, Cara L Haymaker
Journal: Blood
Blood (2023) 142 (Supplement 1): 4760.
https://doi.org/10.1182/blood-2023-188201
Published: 2023
Journal Articles

Daratumumab-Based Maintenance in Patients with Relapsed Multiple Myeloma after Salvage Autologous Hematopoietic Stem Cell Transplantation

Oren Pasvolsky, Krina K. Patel, Qaiser Bashir, Mikael Rauf, Dawen Sui, Samer A. Srour, Mark R. Tanner, Uday R. Popat, Neeraj Y. Saini, Chitra Hosing, Jeremy Ramdial, Elisabet E. Manasanch, Hans C. Lee, Gregory P. Kaufman, Sheeba K. Thomas, Donna M. Weber, Melody R. Becnel, Guilin Tang, Robert Z. Orlowski, Dipa Patel, Richard E. Champlin, Yago Nieto, Elizabeth J. Shpall, Muzaffar H. Qazilbash
Journal: Blood
Blood (2023) 142 (Supplement 1): 7070.
https://doi.org/10.1182/blood-2023-189109
Published: 2023
Journal Articles

Initial Results of a Phase 1 Study of Daratumumab, Ixazomib, and Dexamethasone in Newly Diagnosed and Previously Treated AL Amyloidosis

Hans C. Lee, Gregory P. Kaufman, Lei Feng, Astrid Murga, Ralph J. Johnson, Donna M. Weber, Sheeba K Thomas, Qaiser Bashir, Muzaffar H Qazilbash, Swaminathan P. Iyer, Krina Patel, Melody R. Becnel, Elisabet E. Manasanch, Robert Z. Orlowski
Journal: Blood
Blood (2022) 140 (Supplement 1): 4428–4430.
https://doi.org/10.1182/blood-2022-167555
Published: 2022
Journal Articles

M-Protein Sequencing and Monitoring in Serum of LC-Only Multiple Myeloma Patients

Mariya Liyasova, Natalia Migdal, Zac McDonald, Liqiang Yang, Bin Ma, Jesus Giovanni Piza, Donna E. Reece, Elisabet E. Manasanch, Robert Z. Orlowski, Suzanne Trudel, Gregory P. Kaufman
Journal: Blood
Blood (2021) 138 (Supplement 1): 4729.
https://doi.org/10.1182/blood-2021-149785
Published: 2021
Journal Articles

Disease Characteristics of Multiple Myeloma Involving BRAF Mutations

Shehab Fareed Mohamed, Maliha Khan, Andres Quesada, Junsheng Ma, Pei Lin, C. Cameron Yin, Koji Sasaki, Gautam Borthakur, Naveen Pemmaraju, Qaiser Bashir, Muzaffar H. Qazilbash, Gregory P. Kaufman, Melody R. Becnel
Journal: Blood
Blood (2021) 138 (Supplement 1): 4755.
https://doi.org/10.1182/blood-2021-147400
Published: 2021
Journal Articles

Autologous Hematopoietic Stem Cell Transplantation for AL Amyloidosis Refractory to Induction Therapy

Blessie Elizabeth Nelson, Jeremy L. Ramdial, Qaiser Bashir, Neeraj Saini, Chitra Hosing, Uday R. Popat, Ruby Delgado, Hans C. Lee, Gregory P. Kaufman, Robert Z. Orlowski, Richard E. Champlin, Muzaffar H. Qazilbash, Samer A. Srour
Journal: Blood
Blood (2021) 138 (Supplement 1): 482.
https://doi.org/10.1182/blood-2021-154277
Published: 2021
Journal Articles

A Prospective Phase I/II Trial to Jointly Optimize the Administration Schedule and Dose of Melphalan for Injection (Evomela) As a Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation in Newly Diagnosed Multiple Myeloma

Qaiser Bashir, Peter F. Thall, Dawen Sui, Jeremy L. Ramdial, Samer A. Srour, Rohtesh S. Mehta, Uday R. Popat, Yago Nieto, Neeraj Saini, Partow Kebriaei, Elisabet E. Manasanch, Hans C. Lee, Gregory P. Kaufman, Sheeba K Thomas, Krina K. Patel, Robert Z. Orlowski, Cristina G. Knape, Jitesh D. Kawedia, Richard E. Champlin, Elizabeth J. Shpall, Xiaoqian Liu, Muzaffar H. Qazilbash
Journal: Blood
Blood (2021) 138 (Supplement 1): 3941.
https://doi.org/10.1182/blood-2021-149807
Published: 2021
Journal Articles

Long-Term Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma

Aimaz Afrough, MD, Leonard C Alsfeld, MD, Ruby Delgado, Uday R. Popat, MD, Partow Kebriaei, MD, Betul Oran, MDMS, Neeraj Saini, MD, Samer A. Srour, MD MS, Chitra Hosing, MD, Elisabet E. Manasanch, MD, Hans C. Lee, MD, Gregory P. Kaufman, MD, Krina K. Patel, MD, Robert Z. Orlowski, MDPhD, Chelsea C. Pinnix, MD PhD, Bouthaina S. Dabaja, MD, Sheeba K. Thomas, MD, Donna M. Weber, MD, Elizabeth J. Shpall, MD, Richard E. Champlin, MD, Muzaffar H. Qazilbash, MD, Qaiser Bashir, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 22.
https://doi.org/10.1182/blood-2020-141261
Published: 2020
Journal Articles

Outcomes in Patients with AL (Light-Chain) Cardiac Amyloidosis

Jeremy L. Ramdial, MD, Mahmoud R. Gaballa, MD, Taha Al-Juhaishi, MD, Qaiser Bashir, MD, Samer A. Srour, MD MS, Neeraj Saini, MD, Yago Nieto, MD, Chitra Hosing, MD, Uday R. Popat, MD, Regan Murphy, PA-C, Hans C. Lee, MD, Krina K. Patel, MD, Elisabet E. Manasanch, MD, Sheeba K. Thomas, MD, Donna M. Weber, MD, Gregory P. Kaufman, MD, Robert Z. Orlowski, MDPhD, Richard E. Champlin, MD, Muzaffar H. Qazilbash, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 11–13.
https://doi.org/10.1182/blood-2020-143209
Published: 2020
Journal Articles

Hyperfractionated Cyclophosphamide-Dexamethasone (HyperCy-Dex) with or without Carfilzomib (Car) in Patients (pts) with Multiple Myeloma (MM)

Erin K. Yeung, Pharm.D., Brian R. Primeaux, Pharm.D., Sandra B. Horowitz, Pharm.D., Brandon R. Shank, Irene Y. Lee, Gregory P. Kaufman, MD, Hans C. Lee, MD, Elisabet E. Manasanch, MD, Krina K. Patel, MD, Robert Z. Orlowski, MDPhD, Donna M. Weber, MD, Sheeba K. Thomas, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 19–20.
https://doi.org/10.1182/blood-2020-137704
Published: 2020
Journal Articles

Survival Trends in Multiple Myeloma after Autologous Hematopoietic Stem Cell Transplantation

Samer A. Srour, MD MS, Qaiser Bashir, MD, Denái R. Milton, MS, Yago Nieto, MD, Rohtesh S. Mehta, MDMPH,MS, Neeraj Saini, MD, Ruby Delgado, Gabriela Rondon, Chitra Hosing, MD, Stefan O. Ciurea, MD, May Daher, Uday R. Popat, MD, Issa F. Khouri, MD, Partow Kebriaei, MD, Elisabet E. Manasanch, MD, Gregory P. Kaufman, MD, Krina K. Patel, MD, Elizabeth J. Shpall, MD, Hans C. Lee, MD, Robert Z. Orlowski, MDPhD, Richard E. Champlin, MD, Muzaffar H. Qazilbash, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 24–25.
https://doi.org/10.1182/blood-2020-143196
Published: 2020
Journal Articles

Extensive Changes of the Immune Microenvironment Are Associated with Progression from Precursor Stages to Multiple Myeloma

Elisabet E. Manasanch, MD, Guangchun Han, Zheng Zhang, Minghao Dang, Manisha Singh, Maliha Khan, MD, Shubhra Singh, Hans C. Lee, MD, Krina K. Patel, MD, Gregory P. Kaufman, MD, Behrang Amini, MD PhD, Qaiser Bashir, MD, Samer A. Srour, MD MS, Yago Nieto, MD, Muzaffar H. Qazilbash, MD, Zuzana Berkova, PhD, Pei Lin, MDDM,MDC, Donald Berry, MD PhD, Sheeba K. Thomas, MD, Donna M. Weber, MD, P. Andrew Futreal, Linghua Wang, PhD, Robert Z. Orlowski, MDPhD, Sattva S. Neelapu, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–38.
https://doi.org/10.1182/blood-2020-137555
Published: 2020
Journal Articles

Update of a Phase II Study of Lenalidomide-Elotuzumab As Maintenance Therapy Post-Autologous Stem Cell Transplant (AuSCT) in Patients (Pts) with Multiple Myeloma (MM)

Sheeba K. Thomas, MD, Jatin J. Shah, MD, Armando Morin, M.A., Ashley N. Morphey, M.S.N., Hans C. Lee, MD, Elisabet E. Manasanch, MD, Krina K. Patel, MD, Gregory P. Kaufman, MD, Swami P. Iyer, MD, Lei Feng, MS, Behrang Amini, MD PhD, Muzaffar H. Qazilbash, MD, Qaiser Bashir, MD, Neeraj Saini, MD, Samer A. Srour, MD MS, Ralph J. Johnson, PhD, Brandon N. Crumpton, Mildred D. Stafford, Donna M. Weber, MD, Robert Z. Orlowski, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 46–47.
https://doi.org/10.1182/blood-2020-139934
Published: 2020
Journal Articles

Descriptive Analysis of Isatuximab Use Following Prior Daratumumab in Patients with Relapsed/Refractory Multiple Myeloma

Melody R Becnel, MD, Sandra B. Horowitz, Pharm.D., Sheeba K. Thomas, MD, Swami P. Iyer, MD, Krina K. Patel, MD, Elisabet E. Manasanch, MD, Donna M. Weber, MD, Gregory P. Kaufman, MD, Hans C. Lee, MD, Robert Z. Orlowski, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 20–21.
https://doi.org/10.1182/blood-2020-140526
Published: 2020
Journal Articles

Outcome of Patients with Immunoglobulin Light-Chain Amyloidosis with t(11;14) Undergoing Autologous Hematopoietic Stem Cell Transplantation

Aimaz Afrough, MD, Leonard C Alsfeld, MD, Samer A. Srour, MD MS, Qaiser Bashir, MD, Neeraj Saini, MD, Chitra Hosing, MD, Uday R. Popat, MD, Partow Kebriaei, MD, Elizabeth J. Shpall, MD, Ruby Delgado, Regan Murphy, PA-C, Elisabet E. Manasanch, MD, Hans C. Lee, MD, Gregory P. Kaufman, MD, Krina K. Patel, MD, Sheeba K. Thomas, MD, Donna M. Weber, MD, Robert Z. Orlowski, MDPhD, Richard E. Champlin, MD, Muzaffar H. Qazilbash, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 18–19.
https://doi.org/10.1182/blood-2020-141307
Published: 2020
Journal Articles

Prognostic Impact of Beta 2 Microglobulin in Patients with Immunoglobulin Light-Chain Amyloidosis Undergoing Autologous Hematopoietic Stem Cell Transplantation

Aimaz Afrough, MD, Samer A. Srour, MD MS, Qaiser Bashir, MD, Neeraj Saini, MD, Chitra Hosing, MD, Uday R. Popat, MD, Partow Kebriaei, MD, Elizabeth J. Shpall, MD, Ruby Delgado, Regan Murphy, PA-C, Elisabet E. Manasanch, MD, Hans C. Lee, MD, Gregory P. Kaufman, MD, Krina K. Patel, MD, Sheeba K. Thomas, MD, Donna M. Weber, MD, Robert Z. Orlowski, MDPhD, Richard E. Champlin, MD, Muzaffar H. Qazilbash, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 20–21.
https://doi.org/10.1182/blood-2020-141360
Published: 2020
Journal Articles

PBSC Mobilization for Auto-HSCT in Myeloma: Growth Factors Vs Growth Factors + Chemotherapy

Jeremy L. Ramdial, MD, Junsheng Ma, MS, Denai R. Milton, MS, Ruby Delgado, Qaiser Bashir, MD, Samer A. Srour, MD MS, Neeraj Saini, MD, Yago Nieto, MD, Chitra Hosing, MD, Uday R. Popat, MD, Regan Murphy, PA-C, Hans C. Lee, MD, Krina K. Patel, MD, Elisabet E. Manasanch, MD, Sheeba K. Thomas, MD, Gregory P. Kaufman, MD, Donna M. Weber, MD, Robert Z. Orlowski, MDPhD, Richard E. Champlin, MD, Muzaffar H. Qazilbash, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 6–7.
https://doi.org/10.1182/blood-2020-143108
Published: 2020
Journal Articles

Favorable Long-Term Outcomes after Daratumumab Discontinuation in AL Amyloidosis Patients Achieving Deep Responses

Alfred Chung, MD, Gregory P. Kaufman, MD, Surbhi Sidana, MD, David Iberri, MD, Erik Eckhert, MD MS, Stanley Schrier, MD, Richard Lafayette, MD, Sally Arai, MD, Ronald Witteles, MD, Michaela Liedtke, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1884.
https://doi.org/10.1182/blood-2019-124981
Published: 2019
Journal Articles

Long-Term Outcomes and Organ Responses with Daratumumab Therapy in Previously Treated Patients with AL Amyloidosis

Alfred Chung, MD, Gregory P. Kaufman, MD, Surbhi Sidana, MD, Erik Eckhert, MD MS, Stanley Schrier, MD, Sally Arai, MD, Richard Lafayette, MD, Ronald Witteles, MD, Michaela Liedtke, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1828.
https://doi.org/10.1182/blood-2019-122152
Published: 2019
Journal Articles

Outcomes of Lenalidomide Retreatment with Novel Triplet Regimens in Multiple Myeloma Patients Progressing on Lenalidomide-Based Maintenance Therapy: A Single Center Retrospective Analysis

Chutima Kunacheewa, MD, Lei Feng, MS, Elisabet E. Manasanch, MD, Qaiser Bashir, MBBS, Krina K. Patel, MDMSc, Rohtesh S. Mehta, MD, Gregory P. Kaufman, MD, Swaminathan P. Iyer, MD, Sheeba K. Thomas, MD, Donna M. Weber, MD, Robert Z. Orlowski, MD, PhD, Muzaffar H. Qazilbash, MD, Hans C. Lee, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3198.
https://doi.org/10.1182/blood-2019-130537
Published: 2019